Persistent Asset Partners’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-53
Closed -$2.78K – 194
2024
Q4
$2.78K Buy
+53
New +$2.8K ﹤0.01% 137

Other funds holding JANX

Persistent Asset Partners's JANX Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Janux Therapeutics (JANX) in Q3 2026: 25,745 shares worth $445K. The stake represents 0.12% of the portfolio and ranks #119 among its holdings.

204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • Persistent Asset Partners held 25,745 shares of Janux Therapeutics worth $445K as of Q3 2026.
  • Janux Therapeutics was a new Persistent Asset Partners position in Q3 2026.
  • Janux Therapeutics made up 0.12% of Persistent Asset Partners's portfolio in Q3 2026, its #119 holding.
  • 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.